Oncolytics Biotech
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $33,791,000.

Profit Margin

Oncolytics Biotech Inc. (NASDAQ:ONCY): Profit margin
2014 0 -18.61M
2015 0 -13.72M
2016 0 -15.13M
2017 0 -15.61M
2018 0 -17.03M
2019 0 -45.55M
2020 0 -19.55M
2021 0 -26.30M
2022 0 -24.83M
2023 0 -27.75M

ONCY Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0000000000
Cost of revenue
403K392K452.06K446.18K485.57K95.37K90.76K162.23K180.41K0
Gross profit
-403K-392K-452.06K-446.18K-485.57K-95.37K-90.76K-162.23K-180.41K0
Operating exp.
Research and development
17.70M15.43M12.92M12.94M11.13M9.41M9.39M9.77M8.60M13.82M
Selling and marketing
00-452.49K-445.69K000000
Total operating expenses
33.79M26.92M26.23M25.45M20.69M16.66M15.60M15.29M13.91M18.82M
Operating income
-33.79M-28.56M-26.23M-25.45M-20.69M-16.66M-15.60M-15.29M-13.91M-18.82M
Other income (expenses), net
6.13M3.81M-19.90K2.95M-12.42M173.49K130.10K163.90K197.85K210.39K
Income before tax
-27.65M-24.75M-26.25M-22.50M-33.12M-16.48M-15.47M-15.13M-13.71M-18.61M
Income tax expense
97K84K49.42K-2.95M12.42M548.04K141.49K9.37K3.15K6.77K
Net income
-27.75M-24.83M-26.30M-19.55M-45.55M-17.03M-15.61M-15.13M-13.72M-18.61M
Earnings per share
Basic EPS
-0.41-0.43-0.49-0.48-2.06-1.06-1.12-1.2-1.16-2.01
Diluted EPS
-0.41-0.43-0.49-0.48-2.06-1.06-1.12-1.2-1.16-2.01
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source